- Home
- Applications
- patient blood
Refine by
Patient Blood Product Applications
9 applications found
We adapted an autologous ex-vivo gene therapy method to load the patient’s own TEMs precursors, that are hematopoietic stem and progenitor cells (HSPCs), with an immunotherapeutic transgene sequence. By re-introducing gene-modified HSPCs into the patient, we seek to take advantage of the self-renewing and multi-differentiation capability of HSPCs to enable durable and potentially long-term effects following a single ...
ByGenenta Science based in Milano, ITALY
A NEW WAY TO POWER YOUR DECENTRALIZED CLINICAL TRIALS; Unlock the power of anytime, anywhere blood testing for your program. Tasso Solutions streamline the deployment and execution of at-home testing for ...
ByTasso, Inc. based in Seattle, WASHINGTON (USA)
In the Primary Care segment, blood and urine tests drive nearly 70% of Physician decisions, guiding nearly two-thirds of healthcare ...
ByAtiva Medical based in Shoreview, MINNESOTA (USA)
You need a complete answer to provide the best ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Diabetes is one of the top health issues facing the world today. 422 million people suffer from diabetes worldwide (8.5% of the world population) of which an estimated 29 million are in the US. Of the three types of diabetes (Type 1, Type 2, and gestational), Type 2 accounts for over 90% of the total cases of diabetes. The increased prevalence of diabetes and obesity (a risk factor for Type 2 diabetes) has increased dramatically from 1994 to 2014 and is expected to grow. There are 86 million Americans with ...
ByAlertgy based in Melbourne, FLORIDA (USA)
Expand Your Study’s Reach with Decentralized Patient-Centric Sampling: Enhance your data density and fidelity with Tasso sampling solutions for population pharmacokinetics (PopPK). Our virtually painless, clinical-grade blood collection devices drive recruitment and retention through an improved patient-centric experience that can be completed anywhere. ...
ByTasso, Inc. based in Seattle, WASHINGTON (USA)
A liquid biopsy from Biocept gives you a new tool for profiling breast cancer—with a simple blood ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. This makes characterizing these molecular markers an ...
ByBiocept based in San Diego, CALIFORNIA (USA)
The classical (but rarely observed) malaria attack lasts 6–10 ...
ByAmivas (US), LLC based in Frederick, MARYLAND (USA)